Glomerulonephritis after recombinant hepatitis B vaccine

Pediatric Infectious Disease Journal

Volumn 21, Issue 2, 2002, Pages 172-173

  Pennesi, Marco ^a   Torre, Giuliano ^a   Del Santo, Manuela ^a   Sonzogni, Aurelio ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Glomerulonephritis; Hepatitis B vaccination

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MONOCLONAL ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SAFETY; FEMALE; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIBODIES, MONOCLONAL; BIOPSY; CHILD; FEMALE; GLOMERULONEPHRITIS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; KIDNEY;

EID: 0036171428     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200202000-00020     Document Type: Article

References (7)

1. Visual loss and eosinophilia after recombinant hepatitis B vaccine
2. Nephrotic syndrome associated with recombinant hepatitis B vaccination: A causal relationship or just a mere association?
3. Nephrotic syndrome following hepatitis B vaccination
4. Hepatitis B vaccine side effects
5. Nephrotic syndrome after recombinant hepatitis B vaccine
6. Glomerulonephritis associated with acute hepatitis B
7. Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens